再生元制药 REGN 深 沪
交易中 03-27 10:19:11 美东时间
753.7101
-3.020
-0.40%
华盛通- 最 高794.77
- 今 开758.01
- 成交量 2.68万股
- 最 低 727.88
- 昨 收 756.73
- 总市值 8290.81万
- 52周最高 821.11
- 市盈率 静 10.47
- 换手率 24.32%
- 52周最低 476.4869
- 委 比 98.02%
- 总股本 0.00亿
- 历史最高 1211.1999
- 量 比 0.71
- 振 幅 8.84%
- 历史最低 1.10
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Eupraxia Pharmaceuticals Boasts $900 Million Peak Sales Potential: Analyst
William Blair starts Eupraxia at Outperform as the analyst flags unmet need and sizable market potential.
03-24 01:59
P/E Ratio Insights for Regeneron Pharmaceuticals
In the current market session, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) sto...
03-05 06:00
Why Is CRISPR Therapeutics Stock Surging Thursday?
CRSP shares jump on earnings report, strong pipeline for gene therapy. Revenue grows with increased patient treatment and analyst confidence.
02-27 02:45
Sanofi Stock Near 52-Week Low As Leadership Shakeup Rattles Investors
Sanofi shares drop after CEO exit and pipeline concerns grow, even as Dupixent sales jump in latest quarter.
02-13 21:23
Earnings Summary: Regeneron Pharmaceuticals Q4
The earnings results for Regeneron Pharmaceuticals (NASDAQ:REGN) for Q4 were ma...
01-30 21:48
Earnings Outlook For Regeneron Pharmaceuticals
Regeneron Pharmaceuticals (NASDAQ:REGN) will release its quarterly earnings rep...
01-29 22:01
Tesla, Microsoft, Meta, SanDisk And More: Stocks With Earnings This Week
Earnings season is in full-swing with reports this week from several Mag Seven names, big tech companies, defense primes, telecoms and more.
01-26 21:20
Regeneron Just Moved From Underperform To Buy - Here's Why
Could the tide be turning for Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) after a surprising shift in analyst sentiment?
01-08 05:18
White House Readies Drug Price Deals With AbbVie, Novartis, Roche
AbbVie and other drugmakers may announce U.S. drug pricing deals on Friday as the White House pushes lower prices and Medicare payment reforms.
2025-12-18 23:14
Kymera Stock Smashes 52-Week High As New Pill Crushes Eczema Markers
Kymera Therapeutics released positive clinical results for KT-621 for atopic dermatitis and other allergic diseases.
2025-12-08 22:54
